Tag Archives: AstraZeneca

Highmark Develops Initiatives to Control Drug Spending

Highmark members will receive hemophilia drugs exclusively from three specialty pharmacies

Limited Distribution Networks

Limited Distribution Networks growth continues as Specialty Pharmacies compete to be chosen to distribute specialty pharmaceuticals. AMI’s report, Distribution Decision-Making for Specialty Drugs, found that Pharmaceutical manufacturers typically develop a product-specific distribution strategy dependent on company-specific criteria when bringing a new specialty drug to the market. Pharmaceutical manufacturers consider approximately 100-150 different specialty pharmacies (SPs) […]